These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Atherogenic risk factors in patients with obliterative arteriopathy of the legs]. Scannapieco G; Parisi R; Bortoluzzi C; Doria S; Puato M; Ambrosio GB Minerva Cardioangiol; 1999 Dec; 47(12):579-80. PubMed ID: 10670212 [No Abstract] [Full Text] [Related]
7. The vascular complications of acromegaly. Bondanelli M; Zatelli MC; Ambrosio MR; degli Uberti EC J Endocrinol Invest; 2003; 26(8 Suppl):28-31. PubMed ID: 15233208 [No Abstract] [Full Text] [Related]
8. Risk factors for progression of peripheral arterial disease in large and small vessels. Aboyans V; Criqui MH; Denenberg JO; Knoke JD; Ridker PM; Fronek A Circulation; 2006 Jun; 113(22):2623-9. PubMed ID: 16735675 [TBL] [Abstract][Full Text] [Related]
9. [Control of atherosclerosis in diabetes mellitus]. Quiroz Martínez A Arch Cardiol Mex; 2003; 73 Suppl 1():S125-7. PubMed ID: 12966662 [TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of the pathogenesis of diabetic macroangiopathy]. Tatoń J; Walasik L; Kołaczyński J Pol Tyg Lek; 1982 Dec; 37(51-52):1583-9. PubMed ID: 6763992 [No Abstract] [Full Text] [Related]
11. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50]. Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307 [TBL] [Abstract][Full Text] [Related]
12. [Modern views of diabetic angiopathy of the lower limbs (epidemiology, risk factor, etiopathogenesis, atherosclerosis of diabetes mellitus). Part I]. Losev RZ; Kulikova AN Angiol Sosud Khir; 2005; 11(3):14-20. PubMed ID: 16439944 [TBL] [Abstract][Full Text] [Related]
13. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 3: Hypertriacylglycerolemia. Choluj B; Votruba T Acta Univ Carol Med (Praha); 1991; 37(3-4):116-28. PubMed ID: 1845466 [TBL] [Abstract][Full Text] [Related]
14. [Disorders in the microcirculatory system in experimental dyslipoproteinemia]. Pozdniakov OM; Klimenko ED Vestn Akad Med Nauk SSSR; 1988; (2):35-40. PubMed ID: 3376524 [No Abstract] [Full Text] [Related]
15. A review of the development of large-vessel disease in diabetes mellitus. Colwell JA; Lopes-Virella MF Am J Med; 1988 Nov; 85(5A):113-8. PubMed ID: 3057888 [TBL] [Abstract][Full Text] [Related]
16. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Fadini GP; Sartore S; Albiero M; Baesso I; Murphy E; Menegolo M; Grego F; Vigili de Kreutzenberg S; Tiengo A; Agostini C; Avogaro A Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2140-6. PubMed ID: 16857948 [TBL] [Abstract][Full Text] [Related]
17. [Effects of dyslipoproteinemia on long-term results of surgical treatment of patients with obliterating atherosclerosis of the lower extremity vessels]. Sedov VM; Mirchuk KK; Lebedev LV Vestn Khir Im I I Grek; 2004; 163(2):50-5. PubMed ID: 15199771 [TBL] [Abstract][Full Text] [Related]
20. Which diabetics are at risk for lower-extremity problems and what preventive measures can be taken? Nair DG; Samson R Semin Vasc Surg; 2008 Sep; 21(3):154-9. PubMed ID: 18774451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]